Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US3795772082
Ticker GMED
Company GLOBUS MEDICAL
Currency $
Price
Aware Investor Index (AII) 0.0094
Recommendation STRONG SELL
P/E 55.03
ROE 7.42 %
Capitalization 4,841,891,640 $
Dividend Yield 0.00 %
P/S 6.79
AII Position 621
P/E Position 619
ROE Position 509
Capitalization Position 551
Dividend Yield Position 592
Sales 712,969,000 $
10-Year Average Earnings 87,985,000 $
Shares Outstanding 101,316,000
Equity 1,185,516,000 $
Dividend per Share 0 $
Industry Medical Equipment
Country United States
GLOBUS MEDICAL Investor Relations Web Site http://www.globusmedical.com/investors/sec-filings/







Sales:

YEAR MONTH AMOUNT
2018 12 712,969,000.00 $
2017 12 635,977,000.00 $
2016 12 563,994,000.00 $
2015 12 544,753,000.00 $
2014 12 474,371,000.00 $
2013 12 434,459,000.00 $

Earnings:

YEAR MONTH AMOUNT
2018 12 156,474,000.00 $
2017 12 107,348,000.00 $
2016 12 104,341,000.00 $
2015 12 112,784,000.00 $
2014 12 92,485,000.00 $
2013 12 68,612,000.00 $
2012 12 73,831,000.00 $
2011 12 60,784,000.00 $
2010 12 54,458,000.00 $
2009 12 48,733,000.00 $

Equity:

YEAR MONTH AMOUNT
2018 12 1,185,516,000.00 $
2017 12 967,778,000.00 $
2016 12 832,078,000.00 $
2015 12 715,324,000.00 $
2014 12 585,454,000.00 $
2013 12 472,360,000.00 $
2012 12 386,502,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2018 12 101,316,000
2017 12 97,887,000
2016 12 96,432,000
2015 12 96,073,000
2014 12 95,457,000
2013 12 94,192,000
2012 12 92,208,000

 












Bloomberg News for GLOBUS MEDICAL:



Google News for GLOBUS MEDICAL:

GlobeNewswire (press release) - 21 Feb 2019
Globus Medical Reports Full Year and Fourth Quarter 2018 Results
21, 2019 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its ...
GV Times - 4 hours ago
Chasing The Bull's Tail: Sun Communities, Inc. (SUI), Globus ...
Globus Medical, Inc. (NYSE:GMED) shares appreciated 0.65% over the last trading period, taking overall 5-day performance up to 3.73%.
Fairfield Current
Globus Medical (GMED) Lowered to “Sell” at Zacks Investment ...
Zacks Investment Research lowered shares of Globus Medical (NYSE:GMED) from a hold rating to a sell rating in a research note published on ...
PressOracle
Globus Medical (GMED) stock accomplished price worth of $46.68
Performance Levels. Looking performance record on shares of Globus Medical (GMED) we observed that the stock has seen a move -9.45% ...
Herdon Gazette
Globus Medical's (GMED) CEO Dave Demski on Q4 2018 Results ...
Globus Medical, Inc. (NYSE:GMED) Q4 2018 Earnings Conference Call February 21, 2019 4:30 PM ET. Company Participants. Brian Kearns ...
Fairfield Current - 18 hours ago
Globus Medical, Inc. (NYSE:GMED), Nokian Renkaat Oyj (HLSE ...
Globus Medical, Inc. (NYSE:GMED) has an ERP5 rank of 6042. The ERP5 Rank is an investment tool that analysts use to discover undervalued ...
PressOracle
UPDATE: UBS Upgrades Globus Medical (GMED) to Buy; Robot ...
UBS analyst Matthew Taylor upgraded Globus Medical (NYSE: GMED) from Neutral to Buy with a price target of $55.00. Taylor notes the ...
Baseball Daily News
Critical Analysis: Obalon Therapeutics (NASDAQ:OBLN) versus ...
Globus Medical (NYSE:GMED) and Obalon Therapeutics (NASDAQ:OBLN) are both medical companies, but which is the better stock? We will ...
Stock Voice
Why Globus Medical, Inc.'s (NYSE:GMED) Cash Is A Factor You ...
Two important questions to ask before you buy Globus Medical, Inc. (NYSE:GMED) is, how it makes money and how it spends its cash.
News Leading (press release) - 2 days ago
Globus Medical beats by $0.04, beats on revenue
Globus Medical (NYSE:GMED): Q4 Non-GAAP EPS of $0.43 beats by $0.04; GAAP EPS of $0.36 misses by $0.02. Revenue of $195.94M ...


Back